The clinical relevance of regional lymph node microarchitecture in oesophageal cancer patients - Results from the UK MRC OE02 trial.
Immune cell patterns in lymph nodes independently predict survival in esophageal cancer beyond standard staging, identifying a new prognostic tool.
Using tissue samples from the MRC OE02 randomized trial of oesophageal cancer, this European Journal of Cancer study characterized lymph node microarchitecture and demonstrated its prognostic relevance independent of standard staging variables. The work leverages a well-annotated RCT cohort to validate immune microenvironment features in lymph nodes as clinically meaningful biomarkers for esophageal cancer outcome.
What the study was
- Study design
- translational_cohort
- Population
- Esophageal cancer patients from MRC OE02 RCT cohort
- Category
- Diagnostics
- Maturity
- Exploratory
- Journal
- Eur J Cancer
Why it surfaced
Leverages a landmark RCT (MRC OE02) cohort to establish lymph node immune microarchitecture as prognostic in esophageal cancer—a cancer with poor prognosis and limited biomarkers; potential to refine staging and therapy selection; published in European Journal of Cancer.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.